ALT Q1 2025 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5,000+0.0% YoY

Gross Profit

$5,000100.0% margin

Operating Income

-$22M-436300.0% margin

Net Income

-$20M-391500.0% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$157M

Total Liabilities

$15M

Stockholders' Equity

$142M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5,000	$5,000	+0.0%
Gross Profit	$5,000	-$102,000	+104.9%
Operating Income	-$22M	-$27M	+18.6%
Net Income	-$20M	-$24M	+19.8%